Tech
Telehealth Giant Hims Wants to Test Every Dude for Low Testosterone
The company plans to offer testosterone replacement therapy, marking its first foray into prescribing controlled substances.
Read the full discussion on Wired
This article was aggregated from Wired. Click to join the conversation.
View on Wired
Related Trends in Tech
Apple iPhone Duo Review: Is It Worth It?
A Design Flaw in Share Links Exposes Users’ Personal Conversations With Meta’s Muse
Roku Pro Series OLED TV Review (2026)
Our Favorite Darn Tough Merino Wool Socks Are on Sale at REI
AI Guardrails Aren’t Stopping Criminal Hackers
‘This Is Not a Drill’: Critical PHP Vulnerabilities Are Setting the Internet on Fire